Intrinsic Class D β-Lactamases of Clostridium difficile

Area of Science:

• Microbiology
• Molecular Biology
• Biochemistry

Background:

• Clostridium difficile causes severe infections with high mortality rates.
• Resistance to beta-lactam antibiotics is a major factor in C. difficile infections, but the mechanism remains unknown.
• Beta-lactam antibiotics can disrupt gut microbiota, promoting C. difficile growth.

Purpose of the Study:

• To identify and characterize the beta-lactamase enzymes responsible for beta-lactam resistance in C. difficile.
• To elucidate the role of these enzymes in conferring antibiotic resistance.
• To explore the potential of these enzymes in developing strategies against C. difficile infections.

Main Methods:

• Identification and sequencing of beta-lactamase genes in C. difficile.
• Biochemical characterization of purified beta-lactamase enzymes (CDD-1 and CDD-2).
• Gene expression analysis and functional studies in heterologous expression systems.

Main Results:

• Discovery of intrinsic class D beta-lactamases (CDDs) in C. difficile.
• CDD-1 and CDD-2 enzymes exhibit broad-spectrum activity and high catalytic efficiency against various beta-lactams.
• While native gene expression is low, ectopic expression of cdd1 confers high-level beta-lactam resistance.

Conclusions:

• C. difficile possesses a reservoir of potent class D beta-lactamases capable of conferring clinically relevant resistance.
• These CDDs represent a significant mechanism underlying C. difficile resistance to beta-lactam antibiotics.
• This discovery provides crucial insights for developing novel therapeutic approaches against C. difficile infections.